» Articles » PMID: 12914917

Domain Architecture of the Polyglutamine Protein Ataxin-3: a Globular Domain Followed by a Flexible Tail

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2003 Aug 14
PMID 12914917
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Anomalous expansion of a polyglutamine (polyQ) tract in the protein ataxin-3 causes spinocerebellar ataxia type 3, an autosomal dominant neurodegenerative disease. Very little is known about the structure and the function of ataxin-3, although this information would undoubtedly help to understand why the expanded protein forms insoluble nuclear aggregates and causes neuronal cell death. With the aim of establishing the domain architecture of ataxin-3 and the role of the polyQ tract within the protein context, we have studied the human and murine orthologues using a combination of techniques, which range from limited proteolysis to circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopies. The two protein sequences share a highly conserved N-terminus and differ only in the length of the glutamine repeats and in the C-terminus. Our data conclusively indicate that ataxin-3 is composed by a structured N-terminal domain, followed by a flexible tail. Moreover, [(15)N]glutamine selectively labelled samples allowed us to have a direct insight by NMR into the structure of the polyQ region.

Citing Articles

Cell-Free and In Vivo Characterization of the Inhibitory Activity of Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3.

Sciandrone B, Palmioli A, Ciaramelli C, Pensotti R, Colombo L, Regonesi M ACS Chem Neurosci. 2023; 15(2):278-289.

PMID: 38154144 PMC: 10797631. DOI: 10.1021/acschemneuro.3c00560.


DEPICTER2: a comprehensive webserver for intrinsic disorder and disorder function prediction.

Basu S, Gsponer J, Kurgan L Nucleic Acids Res. 2023; 51(W1):W141-W147.

PMID: 37140058 PMC: 10320100. DOI: 10.1093/nar/gkad330.


Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3.

Luo H, Todi S, Paulson H, Costa M Front Mol Neurosci. 2023; 16:1154203.

PMID: 37122622 PMC: 10140444. DOI: 10.3389/fnmol.2023.1154203.


Ubiquitin-modifying enzymes in Huntington's disease.

Sap K, Geijtenbeek K, Schipper-Krom S, Guler A, Reits E Front Mol Biosci. 2023; 10:1107323.

PMID: 36926679 PMC: 10013475. DOI: 10.3389/fmolb.2023.1107323.


Methodological advances and strategies for high resolution structure determination of cellular protein aggregates.

Schaefer A, Naser D, Siebeneichler B, Tarasca M, Meiering E J Biol Chem. 2022; 298(9):102197.

PMID: 35760099 PMC: 9396402. DOI: 10.1016/j.jbc.2022.102197.